Mavenclad Tablet
NDC Package 44087-4000-4

11-digit billing NDC: 44087400004 · Billing unit: EA · 4 EA per package

Package Information

Mavenclad (cladribine) tablets is mAVENCLAD is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. This formulation utilizes a tablet delivery system. Marketed by Emd Serono, Inc., this product is identified by NDC 44087-4000 and is authorized under FDA application NDA022561.

Identification & Billing

NDC Package Code
44087-4000-4
Package Description
4 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK
Product Code
11-Digit Billing Format
44087400004
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
4 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Mavenclad
Non-Proprietary Name
Cladribine
Substance Name
Cladribine
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
MAVENCLAD is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Because of its safety profile, use of MAVENCLAD is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate drug indicated for the treatment of MS [see Warnings and Precautions (5)].Limitations of UseMAVENCLAD is not recommended for use in patients with clinically isolated syndrome (CIS) because of its safety profile [see Warnings and Precautions (5)].

Regulatory & Marketing

Labeler Name
Emd Serono, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA022561
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-01-2019
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (44087-4000). Click a package code to view its specific billing and regulatory data.

5 BLISTER PACK in 1 CARTON / 2 TABLET in 1 BLISTER PACK
5 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK
6 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK
7 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK
8 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK
9 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 44087-4000-4 identifies a specific commercial package of 4 blister pack in 1 carton / 1 tablet in 1 blister pack of Mavenclad, a human prescription drug labeled by Emd Serono, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 4 billable units per package. This tablet is formulated for oral use and contains cladribine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Emd Serono, Inc. on April 01, 2019. The current certification is valid through December 31, 2027.

How is this Emd Serono, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 44087400004. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 4 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
44087-4000-4
11-Digit CMS (5-4-2)
44087-4000-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.